BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment

Development of a CRISPR-derived technology platform for cancer treatment

06-Mar-2023 - BRAIN Biotech AG announced the signing of a joint development agreement (JDA) with TransCode Therapeutics, Inc. The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit ...

Strategic partnership of European biotech experts for the production of animal-free milk protein

BRAIN Biotech to help Formo scale production of bioidentical milk protein with proprietary genome editing technology

10-Feb-2022 - BRAIN Biotech AG and Formo Bio GmbH are launching a strategic collaboration to further advance the production of animal-free milk proteins. BRAIN Biotech is a leading industrial biotechnology company, Formo is a pioneering food-tech startup in the space of alternative milk protein. As experts in ...

Change at the top of the Management Board of BRAIN AG

03-Dec-2019 - The company announces, that the Supervisory Board appointed Adriaan Moelker to the Management Board with effect from 1 February 2020 and appointed him as the future Chairman of the Board (CEO). Dr Jürgen Eck, co-founder of BRAIN, Chief Technology Officer (CTO) for around 26 years as well as CEO ...

BRAIN AG announces strategic collaboration with BluCon Biotech GmbH

Joint R&D work aims at microbial strain development for the production of high-value chemicals including bioplastics

19-Sep-2018 - BRAIN AG announced the start of a strategic research and development collaboration with BluCon Biotech GmbH. The objective of the joint research efforts is the identification and development of special microbial production strains. The collaboration will run several months with the option for ...

Biological processing of precious metal ores

BRAIN AG and CyPlus GmbH develop disruptive technologies

25-Jun-2018 - The bioeconomy company BRAIN AG and CyPlus GmbH have announced the development of an initial range of market-relevant products for the global mining industry. This work has been carried out as part of a multi-year collaboration between the companies in the area of biological ore processing to ...

BRAIN AG acquires majority stake in Biocatalysts

20-Mar-2018 - The BRAIN AG announces the signing of a share purchase agreement between BRAIN and Biocatalysts Ltd. based in Cardiff, Great Britain, and active in the field of speciality enzymes. Therein the takeover of the majority stake of Biocatalysts’s shares by BRAIN is governed. The transaction will be ...

BRAIN AG establishes US subsidiary

07-Mar-2018 - In order to address the North American markets of importance for the BRAIN Group more effectively, the BRAIN AG, headquartered in Zwingenberg, has founded the US subsidiary B.R.A.I.N. Biotechnology Research and Information Network US LLC (short: BRAIN LLC). This strategic step is intended to ...

Low-impact copper production through bio-leaching

Bio-leaching process allows copper to be extracted almost completely from shale deposits

30-Oct-2017 - An international research team involving scientists from BRAIN AG has succeeded in extracting nearly the entire copper content from local shale deposits harnessing micro-organisms in combination with a bio-leaching process. For the Franco-German research project, co-managed by the French Geology ...

Successful conclusion of joint BRAIN AG and BASF SE research project

Objective of the collaboration was the identification and development of new active ingredients for cosmetics

03-Aug-2017 - Following several years of exclusive cooperation between BRAIN AG and BASF SE on the basis of a joint research project, BRAIN announced the successful conclusion of the project. The objective of the two companies’ collaborative research efforts was the identification and development of ...

BRAIN on growth track in the first half-year 2016/17

31-May-2017 - B.R.A.I.N. Biotechnology Research and Information Network AG published its financial results for the first half of fiscal year 2016/17. Accordingly, during the reporting period from October 1, 2016, to March 31, 2017, the BRAIN Group grew its total operating performance by 3 percent from € 13.0 ...